echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Int Med: Obesity may increase the risk of death in COVID-19 patients, especially young men.

    Ann Int Med: Obesity may increase the risk of death in COVID-19 patients, especially young men.

    • Last Update: 2020-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    AUGUST 17, 2020 // -- In a recent study published in the international journal Annals of Internal Medicine, scientists from Kaiser Medical Center in Southern California and other institutions found a significant association between the risk of death or BMI in patients with COVID-19, and that this association does not depend on obesity-related diseases and other potential disruptive factors.
    the results of this paper show that there is a significant association between the mortality rate of COVID-19 and the higher BMI in both young and male patients, but this association does not appear to exist in female patients and the elderly population.
    Photo Source: In the CC0 Public Domain study, researchers analyzed the medical records of more than 6,900 COVID-19 patients recruited to The Kaiser Health System in Southern California between February and May 2020 to determine the association between obesity and COVID-19 deaths; Failure, myocardial infarction, and chronic lung or kidney disease are themselves risk factors for poor prognosis in patients with COVID-19, and the study also took into account the timing of SARS-CoV-2 testing in patients, who found that the mortality rate in the higher weight group was four times higher in the 21 days after being diagnosed with COVID-19 than in the normal weight group.
    researchers point out that the risk of death is particularly high for men and high-weight patients under 60, and that it is important to use obesity as an independent risk factor so that obese patients can take additional precautions, and health care providers and public health officials need to consider when to provide public health interventions.
    Then, researchers from Hopkins University published an editorial in which they suggested that combining the findings of this paper with previous studies might dispel the idea that obesity is common in severe COVID-19 patients because obesity is also common in the general population, and that the study confirms that obesity is a severe COVID-A very important independent risk factor in 19 diseases, and the risk is higher among young patients, may not be because obesity is particularly harmful to the younger population, but other serious co-diseases that are more likely to develop later in an individual's life may be the main risk factor, and men in particular may be affected, which may reflect the fact that male groups are more likely than female groups to develop visceral obesity.
    original source: Sara Y. Tartof, PhD, MPH, Lei Qian, PhD, MS, Vennis Hong, et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization, Annals of Internal Medicine (2020). DOI: 10.7326/M20-3742.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.